Longwood Fund

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events
  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

Merck KGaA, Darmstadt, Germany Selects ArcherDX for Strategic Global Companion Diagnostic Assay Development Collaboration

October 3, 2018

Recros Medica Unveils the Nuvellus™ Brand for Its Novel Rotational Fractional Resection Technology

September 27, 2018

Verastem Wins FDA Approval for Blood Cancer Drug

September 25, 2018

Needham-based Verastem Oncology won its first drug approval Monday, a medicine that treats three forms of blood cancer.

Millendo Therapeutics Appoints Acceleron CEO Habib Dable to its Board of Directors

September 25, 2018

Verastem Oncology Signs Exclusive License Agreement for the Development and Commercialization of COPIKTRA™ (duvelisib) in China

September 25, 2018

Longwood-Founded Verastem Oncology Receives FDA Approval of COPIKTRA™ (duvelisib) Capsules

September 24, 2018
« Older Entries
Newer Entries »

Longwood Fund

The Prudential Tower

800 Boylston Street
Suite 1715
Boston, MA, 02199

  • About
  • Portfolio
  • Team
  • Press
  • Investor Login
  • Industry Events

© Longwood Fund. All Rights Reserved